← Browse by Condition
Medical Condition

adenovirus

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 3, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for adenovirus sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — adenovirus Clinical Trials

How many clinical trials are currently recruiting for adenovirus?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for adenovirus, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for adenovirus?
adenovirus research spans Phase 1 (2 trials), Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a adenovirus clinical trial?
Eligibility criteria for adenovirus trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
2
Phase 3
1
Top Sponsors
Institut Pasteur du Cambodge 1 trial
St. Jude Children's Research Hospital 1 trial
New York Medical College 1 trial
Jessie L. Alexander 1 trial
Columbia University 1 trial

Recruiting Clinical Trials

NCT07358910
Recruiting
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Enrollment
10,000 pts
Location
Cambodia
Sponsor
Institut Pasteur du Cambodge
View Trial →
NCT05664126 Phase 2
Recruiting
Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation
Enrollment
42 pts
Location
United States
Sponsor
St. Jude Children's Research H...
View Trial →
NCT07225972 Phase 3
Recruiting
Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone
Enrollment
138 pts
Location
United States
Sponsor
New York Medical College
View Trial →
NCT06909110 Phase 1, Phase 2
Recruiting
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Enrollment
25 pts
Location
United States
Sponsor
Jessie L. Alexander
View Trial →
NCT05183490 Phase 1
Recruiting
R-MVST Cells for Treatment of Viral Infections
Enrollment
36 pts
Location
United States
Sponsor
Columbia University
View Trial →

Related Conditions

cytomegalovirus infections (3) cytomegalovirus (2) epstein barr virus infections (2) dengue (1) chikungunya (1) zika virus infection (1) japanese encephalitis (1) west nile virus (1) tick borne encephalitis tbe (1) severe fever with thrombocytopenia syndrome (1) nipah virus infection (1) hantavirus infections (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology